A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
UCL Corporate Partnerships team expands
21 October 2013
UCL Corporate Partnerships has recently expanded its team with the addition of Dr Michael Morris, who will be working as Corporate Partnerships Manager for The School of the Built Environment, Engineering Sciences, and Mathematical and Physical Sciences (BEAMS).
Michael is a UCL alumnus, having completed a PhD at the university in Organic Chemistry, and also has a BA in Natural Sciences from Cambridge.
He rejoins UCL having gained corporate experience in telecommunications at both British Telecom and Nokia. Reporting to Dr Anna Clark, Director of UCL Corporate Partnerships, Michael will be heavily involved with current projects to build fruitful collaborations, including the triple-helix collaboration – a university working with a corporate partner and government support – with both Cisco and Intel, while also developing his own strategic partnerships.
UCL Corporate Partnerships will continue to expand in the coming months, and are hoping to shortly recruit a new Corporate Partnerships Manager for the School of Arts & Humanities, Laws, Social & Historical Sciences and SSEES (SLASH).
About UCL Corporate Partnerships
UCL Corporate Partnerships develops and manages successful long-term relationships between industry and UCL and responds to corporate and academic needs through tailored partnerships, high-value research initiatives and global leadership projects. Corporate Partnerships deliver innovation benefits to industry, enhance the international reputation of companies, and generate sustainable revenue and benefits to the University.
For further information, please visit www.ucl.ac.uk/corporate-partnerships